|
|
市場調査レポート
商品コード
1637689
欧州の放射線腫瘍学市場:2031年までの予測 - 地域別分析 - タイプ別、用途別Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application |
||||||
|
|||||||
| 欧州の放射線腫瘍学市場:2031年までの予測 - 地域別分析 - タイプ別、用途別 |
|
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 87 Pages
納期: 即納可能
|
全表示
- 概要
- 図表
- 目次
欧州の放射線腫瘍学市場は、2023年に33億1,721万米ドルとなり、2031年までには87億2,307万米ドルに達すると予測され、2023年から2031年までのCAGRは12.8%を記録すると推定されます。
放射線腫瘍学の市場開拓を支援する取り組みが欧州の放射線腫瘍学市場を牽引
政府や組織は、放射線治療を用いた迅速かつ効果的ながん治療のためのミッションやプログラムを導入しています。2023年9月、国際原子力機関(IAEA)は放射線治療のインフラ整備を目的としたRays of Hope-フラッグシップがんイニシアチブを発表しました。米国、ドイツ、英国、フランスなどの先進諸国では、ほぼすべての患者が放射線治療を受けることができます。中所得国では患者の60%、低所得国では患者の10人に1人が放射線治療を受けることができます。Rays of Hope Cancer Care for Allは、世界中の放射線治療サービスの開発に焦点を当てています。このイニシアチブの開始以来、さまざまな国々が放射線治療機器と、タイムリーな診断と治療のための機器操作に必要なトレーニングを受け取っています。このイニシアチブには5大陸すべてが参加しており、米国から4,550万米ドル(4,200万ユーロ)が拠出され、民間部門からは76万8,902ドル(71万ユーロ)が支援のために投資されました。さらに、ElektaなどのメーカーがIAEAとパートナーシップを結び、放射線治療機器を世界中に提供することで、がん治療の改善に貢献しています。さらにIAEAは、放射線腫瘍医14名、医学物理士13名、核医学技師4名、核医学医師7名、放射線薬理士7名、放射線治療技師16名、腫瘍看護師7名、医療画像診断技師4名、放射線技師7名など、さまざまな分野のヘルスケア専門家のトレーニングを開始しました。そのため、放射線治療への取り組みが急増しており、訓練を受けた専門家や放射線治療インフラの市場開拓とともに、低所得国での普及が進むと予想され、放射線腫瘍学市場の今後の成長を後押ししています。
欧州の放射線腫瘍学市場の概要
ドイツは、放射線治療の実施を支援する最先端技術を利用できる高度なヘルスケアインフラを有しています。同国はまた、技術革新と研究に力を入れていることでも有名です。ドイツで運営されている総合がんセンターは、放射線治療、手術、化学療法、その他の医療処置を組み込んだ集学的治療計画を提供しています。2020年、Varianはハイデルベルクのドイツがん研究センター(DKFZ)が、同国初のEthos治療であるAdaptive Intelligenceソリューションを発注したと発表しました。このAIを搭載した包括的なソリューションは、放射線治療の有効性、適応性、能力を向上させることを目的としています。
欧州の放射線腫瘍学市場の収益と2031年までの予測(金額)
欧州の放射線腫瘍学市場のセグメンテーション
欧州の放射線腫瘍学市場は、タイプ、用途、国に分類されます。
タイプ別に見ると、欧州の放射線腫瘍学市場は外照射療法と内照射療法に二分されます。2023年の市場シェアは、外照射療法分野が大きくなりました。
用途別では、欧州の放射線腫瘍学市場は乳がん、前立腺がん、肺がん、頭頸部がん、子宮頸がん、その他に分類されます。2023年には乳がん分野が最大の市場シェアを占めました。
国別では、欧州の放射線腫瘍学市場はドイツ、英国、フランス、スペイン、イタリア、その他欧州に区分されます。2023年の欧州の放射線腫瘍学市場シェアはドイツが独占しました。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide(Ion Beam Applications SA)、Becton Dickinson and Co、Nordion、Mevion Medical Systems、NTP RADIOISOTOPES、Mallinckrodt Plc、Curiumは、欧州の放射線腫瘍学市場で事業を展開している主要企業です。
目次
第1章 イントロダクション
第2章 エグゼクティブサマリー
- 主要な洞察
第3章 調査手法
- 2次調査
- 1次調査
- 仮説の策定
- マクロ経済要因分析
- 基礎数値の開発
- データの三角測量
- 国レベルのデータ
第4章 欧州の放射線腫瘍学市場:主要市場力学
- 市場促進要因
- がんの有病率の増加
- 放射線腫瘍学の開発を支援する取り組み
- 市場抑制要因
- 放射線治療機器の高コスト
- 市場機会
- 放射線腫瘍学における戦略的イニシアティブ
- 今後の動向
- 放射線腫瘍学の技術進歩
- 促進要因と抑制要因の影響
第5章 放射線腫瘍学市場:欧州市場分析
- 放射線腫瘍学市場の収益、2021年~2031年
第6章 放射線腫瘍学の欧州市場分析:タイプ別
- 外部ビーム放射線療法
- 内部ビーム放射線療法
第7章 放射線腫瘍学の欧州市場分析:用途別
- 乳がん
- 前立腺がん
- 肺がん
- 頭頸部がん
- 子宮頸がん
- その他
第8章 欧州の放射線腫瘍学市場:国別分析
- 欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他欧州
第9章 放射線腫瘍学市場:業界情勢
- 放射線腫瘍学市場における成長戦略
- 有機的成長戦略
- 無機的成長戦略
第10章 企業プロファイル
- Varian Medical Systems Inc
- Elekta AB
- Accuray Incorporated
- IBA Worldwide(Ion Beam Applications SA)
- Becton Dickinson and Co
- Nordion
- Mevion Medical Systems
- NTP RADIOISOTOPES
- Mallinckrodt Plc
- Curium
第11章 付録
List Of Tables
- Table 1. Europe Radiation Oncology Market Segmentation
- Table 2. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 3. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 4. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 5. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 6. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 7. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 8. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 9. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 10. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 11. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 12. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 13. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 14. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 15. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 16. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 17. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 18. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 19. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 20. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 21. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 22. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
- Table 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
- Table 24. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
- Table 25. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
- Table 26. Recent Organic Growth Strategies in Radiation Oncology Market
- Table 27. Recent Inorganic Growth Strategies in the Radiation Oncology Market
- Table 28. Glossary of Terms, Radiation Oncology Market
List Of Figures
- Figure 1. Europe Radiation Oncology Market Segmentation, by Country
- Figure 2. Radiation Oncology Market - Key Market Dynamics
- Figure 3. Statistics at Glance, Global, 2022
- Figure 4. Impact Analysis of Drivers and Restraints
- Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
- Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
- Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
- Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- Figure 16. Europe Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
- Figure 17. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
- Figure 18. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 19. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 20. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 21. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 22. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 23. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
- Figure 24. Growth Strategies in Radiation Oncology Market
The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.
Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market
The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the "Rays of Hope"-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The "Rays of Hope Cancer Care for All" focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.
Europe Radiation Oncology Market Overview
Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.
Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
Europe Radiation Oncology Market Segmentation
The Europe radiation oncology market is categorized into types, application, and country.
Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Radiation Oncology Market - Key Market Dynamics
- 4.1 Market Drivers:
- 4.1.1 Increasing Prevalence of Cancer
- 4.1.2 Initiatives to Support Developments in Radiation Oncology
- 4.2 Market Restraints
- 4.2.1 High Cost of Radiotherapy Equipment
- 4.3 Market Opportunities
- 4.3.1 Strategic Initiatives in Radiation Oncology
- 4.4 Future Trends
- 4.4.1 Technological Advancement in Radiation Oncology
- 4.5 Impact of Drivers and Restraints:
5. Radiation Oncology Market - Europe Market Analysis
- 5.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
6. Europe Radiation Oncology Market Analysis - by Types
- 6.1 External Beam Radiation Therapy
- 6.1.1 Overview
- 6.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 6.2 Internal Beam Radiation Therapy
- 6.2.1 Overview
- 6.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7. Europe Radiation Oncology Market Analysis - by Application
- 7.1 Breast Cancer
- 7.1.1 Overview
- 7.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Prostate Cancer
- 7.2.1 Overview
- 7.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Lung Cancer
- 7.3.1 Overview
- 7.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Head and Neck Cancer
- 7.4.1 Overview
- 7.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 7.5 Cervical Cancer
- 7.5.1 Overview
- 7.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. Europe Radiation Oncology Market - Country Analysis
- 8.1 Europe
- 8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
- 8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.1.1 Germany: Radiation Oncology Market Breakdown, by Types
- 8.1.1.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.1.4 Germany: Radiation Oncology Market Breakdown, by Application
- 8.1.1.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
- 8.1.1.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
- 8.1.1.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.3.1 France: Radiation Oncology Market Breakdown, by Types
- 8.1.1.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.3.4 France: Radiation Oncology Market Breakdown, by Application
- 8.1.1.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.4.1 Spain: Radiation Oncology Market Breakdown, by Types
- 8.1.1.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.4.4 Spain: Radiation Oncology Market Breakdown, by Application
- 8.1.1.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.5.1 Italy: Radiation Oncology Market Breakdown, by Types
- 8.1.1.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.5.4 Italy: Radiation Oncology Market Breakdown, by Application
- 8.1.1.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
- 8.1.1.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
- 8.1.1.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
- 8.1.1.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
- 8.1.1.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
- 8.1.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
9. Radiation Oncology Market - Industry Landscape
- 9.1 Overview
- 9.2 Growth Strategies in Radiation Oncology Market
- 9.3 Organic Growth Strategies
- 9.3.1 Overview
- 9.4 Inorganic Growth Strategies
- 9.4.1 Overview
10. Company Profiles
- 10.1 Varian Medical Systems Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview (Siemens Healthineers AG)
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
- 10.2 Elekta AB
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
- 10.3 Accuray Incorporated
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
- 10.4 IBA Worldwide (Ion Beam Applications SA)
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
- 10.5 Becton Dickinson and Co
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
- 10.6 Nordion
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
- 10.7 Mevion Medical Systems
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
- 10.8 NTP RADIOISOTOPES
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
- 10.9 Mallinckrodt Plc
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
- 10.10 Curium
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments
11. Appendix
- 11.1 About The Insight Partners
- 11.2 Glossary of Terms






